helping to regulate the levels of nitrite.
14 This is beneficial, as metabolic studies show nitric oxide is important for maintaining cardiovascular health through improved mitochondrial function and reduced blood pressure. 15 Decreased oral health has been linked to systemic co-morbidities. Brushing and invasive dental procedures allow bacteria to enter the bloodstream and disseminate to other sites, such as the brain, lungs, and liver, linking oral diseases to a vast array of health issues from pregnancy complications to respiratory, cardiovascular, and cerebrovascular diseases. 16 
| CHANGES IN THE MICROBIOME LEAD TO DISEASE
Typically, with proper oral hygiene, the oral microbiome exists in a beneficial or benign state. Changes to that natural state can lead to the onset of two of the most common bacterial infections, dental caries and periodontal disease. 17 Host factors such as genetic susceptibility, smoking, diabetes mellitus, age and poor oral hygiene can lead to systemic changes (chronic inflammation and altered immune response) associated with the disruption of the oral ecosystem. 18 Additionally, microbial interactions play a significant role. Based on the current keystone-pathogen hypothesis, it has been shown that certain species can act as community activators by transforming the surrounding environment. 19 These changes create a dysbiotic environment that decreases the healthy microbial diversity and favors the growth of oral pathogens that contribute to the development of oral diseases.
Periodontitis is associated with the keystone-pathogen hypothesis.
In clinically healthy hosts, the population is maintained in homeostasis, being predominately colonized by gram-positive oral streptococci.
Colonization by Porphyromonas gingivalis can selectively modify the host immune response to prevent cell clearance and allow for cytokines that are involved in bone resorption and tissue degradation to generate a nutrient-rich, inflamed site. The now altered oral environment selects for asaccharolytic organisms, such as P. gingivalis, which can use available nutrients. In addition, the degeneration of alveolar bone provides new niches for pathogenic species to colonize. 19 For dental caries, an increase in carbohydrate intake can disrupt the oral environment, selecting for cariogenic bacteria such as S. mutans, Streptococcus sobrinus, and Lactobacillus spp. 20 These acidogenic bacteria metabolize dietary sugars, producing acid by-products and creating a low-pH environment that weakens the tooth enamel leading to tooth decay. This also contributes to dysbiosis, as the normal acid-sensitive population is eliminated, further encouraging the colonization of cariogenic bacteria such as S. mutans.
| THE CALL FOR TARGETED ANTIMICROBIAL THERAPY
Unfortunately, treatment for advanced oral diseases relies on the non-specific removal of dental plaque. 21 Although oral infections are associated with polymicrobial environments, the total eradication of the microbiome often leads to increased susceptibility to infection and disease re-occurrence. 22 The indiscriminate removal of the oral population allows for the recolonization of the pathogen and may lead to pathogenic species becoming dominant, decreasing the normal, healthy microbial diversity. 23 It may be more prudent to only remove the dysbiotic species to allow for restoration of the normal population. In caries infections, clinical studies suggest that the absence of S. mutans provides a protective benefit. Children who are not colonized with S. mutans at an early age show a lower risk of caries development, which may contribute to the colonization resistance effect of a developed microbiome. 24 Similarly, the presence of P. gingivalis is closely associated with clinical outcomes of periodontitis. Porphyromonas gingivalis has been found in 85% of patients with periodontitis and is isolated at higher levels from areas of disease progression compared with healthy sites. 25, 26 In an animal periodontitis model, vaccinating against a major P. gingivalis virulence factor reduced alveolar bone loss, decreased pathogen colonization, and improved disease outcome. 27 Clinical trials using human patients showed that repeated applications of monoclonal antibodies specific to a P. gingivalis protease complex prevented recolonization of the pathogen for approximately 9 months, leading to a significant improvement in oral health. 28 By targeting key pathogens, such as P. gingivalis and S. mutans, it may be possible to treat periodontitis or dental caries while allowing for the protection of the beneficial, commensal flora and reducing the chance for antibiotic resistance. This brings in to play the rationale for alternative strategies such as targeted or pathogenic-selective antimicrobials. Narrow-spectrum production can be more cost effective long term and antibiotics designed against a limited population may also lead to faster discovery rates as targets will not need to be conserved or effective across a range of disparate species. 29 With antibiotic resistance and the necessity of maintaining the healthy microbial population leaving few good treatment options available, novel approaches in antimicrobial development are imperative.
In this review, we examine targeted strategies explored in the oral cavity. It is impossible to say one species is completely responsible for periodontitis or dental caries, but studies have clearly linked certain pathogens to their progression, making the oral microbiome an excellent model for this strategy. Although not comprehensive and although the application of novel strategies within the oral microbiome is still in its infancy, we focus on a few studies aimed selectively against oral pathogens including targeted delivery systems and our own selective drug discovery project, exploiting pathogenic essential genes. We will also address what is needed for the successful development of novel antibiotics in the microbiome era.
| STRATEGIES APPLIED AGAINST PERIODONTAL PATHOGENS

| Targeting pathogenic essential genes
Essential genes are critical for the growth and survival of an organism and therefore present an ideal pool of potential drug targets. Due to essential genes being characteristically conserved, 30 target-based screens undertaken in the early years of the genomics era used a broad-spectrum approach for drug discovery. A bioinformatics approach was applied to select genes conserved across a diverse population of essential genes not associated with minimal or rich media. These genes were connected to membrane synthesis including the outer membrane lipoprotein, OprI, and a hypothetical outer membrane chaperone. 32 These variations in cell requirements can produce a different set of essential pathways and essential genes that may aid in selecting targets against a limited range of bacteria.
We undertook this approach by focusing on a pathogen-selective target against the gram-negative periodontal pathogen, P. gingivalis. 33 We previously conducted a genome-wide essential gene identification study in the gram-positive, early oral colonizer Streptococcus sanguinis using systematic single and double gene deletions. Once experimentally identified, the essential genes were grouped by specific categories based on their KEGG functional annotation. When linked together, we were able to create a model of essential pathways and determined that essential genes were conserved within three major categories of biological function: maintenance of the cell envelope, energy production and processing of genetic information. The underlying benefit of this study was that we discovered general rules for essential genes, providing us with the basis for predicting essential genes in other organisms
including Staphylococcus aureus, Bacillus subtilis, Streptococcus pneumoniae, 34 and recently for P. gingivalis and Mycobacterium tuberculosis. Our essential gene predictions were confirmed and shown to be highly accurate in a comparison with genome-wide gene knock-out experimental data performed in other laboratories (>90% accuracy).
Our prediction does not rely on sequence features among different species, but a gene's contribution to an essential end product. Even though the essential gene itself may differ, the overall essential function remains unchanged. We believe the reliance on genomic function and not sequence, addresses inconsistencies of essential gene data among different bacterial species as a result of genetic diversity while still allowing for an accurate prediction. This suggested that the general rule for essential genes identified through our experimental studies in S. sanguinis, could be universally applied for different bacterial species including gram-negative bacteria.
Based on our prediction in P. gingivalis strain W83, 212 genes were essential. Of these, 46 genes fell into the maintenance of the cell envelope category. About 32% (7% of total predicted essential genes)
of those genes were directly related to peptidoglycan biosynthesis whereas about 19% (4% of total) were related to fatty acid biosynthesis. Sixteen genes were involved in energy production with about 69% (5% of total) related to glycolysis. The majority of the predicted essential genes (148 genes) were grouped into the processing of genetic information category. About 9% (6% of total) were related to nucleotide biosynthesis including both purine and pyrimidine metabolism while 33% (24% of total) were related to ribosomal biosynthesis.
Additionally, two genes were involved in the synthesis of cofactors for riboflavin. Although this prediction may not be comprehensive due to a lack of annotated biological data (ie hypothetical genes), the functional classification fell in line with recent experimental essential gene studies in P. gingivalis ATCC 33277. 35, 36 As the healthy oral cavity comprises roughly 80% streptococcus species, 37 it was theorized that selecting essential genes in P. gingivalis that were absent or not essential within S. sanguinis would pres- interferring with cell wall, 44 DNA, 45 and protein synthesis. 46 Although antimicrobial peptides have proven to be effective, this process is non-specific, targeting a broad range of gram-negative and grampositive bacteria. To circumvent this, Eckert et al., designed a novel class of AMPs, which were named specifically targeted antimicrobial peptides (STAMPs), against the cariogenic pathogen, S. mutans. 47 The STAMP, C16G2, consists of the non-specific linear antimicrobial peptide that possesses broad-spectrum killing activity. This is linked together with a targeted binding peptide containing a fragment of the S. mutans specific competence stimulation peptide (CSP). This targeting region increases binding onto the surface of the intended target, therefore increasing the antimicrobial activity and cell clearance. 48 When tested, C16G2 showed strong bactericidal activity against sev- 54 However, this did not appear to increase the antimicrobial activity against P. gingivalis or decrease activity against other species.
Although successful with S. mutans and the species-specific competence peptide, a conjugated, pathogen-specific targeting domain may be difficult to design. However, due to the potency of AMPs, targeted
AMPs present promising alternatives to conventional approaches.
| Inhibition of pathogenic biofilm
Biofilms are bacterial communities encased within an extracellular matrix composed of exopolysaccharides, proteins, lipids, DNA, and ions. These structures are ubiquitous in nature and represent a major health concern because they are a cause of persistent infections and are estimated to account for 80% of all bacteria-related infections.
They provide the bacteria with protection from external stresses and decrease their susceptibility to antimicrobial therapy and immune clearance, making treatment extremely difficult. 55 The establishment of biofilms within the oral cavity is essential for the formation of dental plaque and the subsequent development of oral diseases. Oral streptococci, particularly S. mutans, can use sucrose obtained from the diet to synthesize extracellular and intracellular polysaccharides. 56, 57 Bacterial exopolysaccharides are a primary component of the extracellular polymeric substances in biofilms and serve as a scaffold for the attachment of S. mutans to the tooth surface and allow colonization by other bacteria. Along with colonization and protection, the biofilm architecture facilitates an environment favorable to the survival of cariogenic pathogens. The development of three-dimensional structures allows for the creation of water channels that connect to transport nutrients and signaling molecules and preserve the low-pH conditions. 58, 59 Molecules that could specifically inhibit the formation or disperse biofilms formed by S. mutans could be a unique strategy for controlling dental caries. There are several strategies to control biofilm development, such as inhibiting attachment, preventing cell-cell communication or promoting the dispersal of the exopolysaccharides. 60 These inhibitors are typically derived from natural products such as garlic, ginseng, cranberry, and bacteriophages. This method has been shown to be effective against dental caries with several studies indicating antibiofilm activity within the oral cavity [61] [62] [63] ; however, the compounds are non-specific and run the risk of promoting dysbiosis. Recent studies by Garcia et al. identified a small-molecule inhibitor that selectively dispersed biofilms formed by S. mutans but did not significantly affect the cell viability. 64 The group screened 600 compounds and identified 3F1, based on 2-aminoimidazole, a derivative of bromoageliferin from marine-sponge products that may structurally mimic quorum-sensing molecules, contributing to their ability to disperse biofilms. 65, 66 These compounds have previously displayed anti-biofilm activity against various microorganisms, including Pseudomonas aeruginosa, Acinetobacter baumannii, and Bordetella bronchispetica. 67 However, the mechanism of action is unclear. The anti-biofilm effect was still observed when tested against deletion mutants involved in the initial development of the biofilm such as the glucosyltransferase enzymes responsible for the synthesis of glucans and eDNA within the structure. It is speculated that the small molecule may interact with proteins related with the biofilm architecture. The compound did not affect in vitro biofilms formed by commensals S. sanguinis and S. gordonii nor the mutans family member S. sobrinus. More promising was the consistency of the oral microbiota when 3F1 was administered in a rat caries model.
Sequencing following a 4-week treatment showed fewer S. mutans compared with the no treatment control but no significant changes in the colonization at the phylum level. This work was based on their previous studies. 65 A focused library of 506 small molecules based on the 2-aminoimidazole backbone was used to identify eight compounds that inhibited S. mutans biofilm by at least 50%. These compounds altered the normal three-dimensional structure, leading to a thinner structure, but did not affect the biofilm of S. sanguinis or S. gordonii.
However, the most active compound did exhibit slight bactericidal activity against S. mutans, S. sanguinis and S. gordonii when cultured in a mixed-species. Interestingly, these compounds appeared to affect the production of antigen I/II and the glucosyltransferases, indicating a potential mechanism of specificity. As the biofilm is a key virulence factor in the pathogenesis of S. mutans, identifying an agent that prevents biofilm establishment could be an effective strategy. However, it is not clear whether the dispersal of the biofilm without specifically inhibiting cell growth would lead to long-term clinical benefits. Viable S. mutans within a dispersed biofilm may disseminate and colonize at other sites, leading to its re-establishment within the oral cavity. Antibiofilm agents may be most effective in conjunction with targeted antimicrobials as the removal of the biofilm would allow for easier penetration of the drug.
| FUTURE STRATEGIES FOR THE DEVELOPMENT OF TARGETED ANTIMICROBIAL THERAPY
As the microbiome is a complex system, it is necessary to thoroughly understand the microbial composition and its link to health and disease. Although the oral microbiome has been studied for years and there is a baseline for a healthy vs diseased population, other sites are not as clearly characterized. Unfortunately, many microorganisms cannot be cultured using standard laboratory techniques and this could leave out a significant contributor to the environmental ecology. Culture-independent approaches offer a powerful tool to analyze diverse microbial communities. 68 Next-generation sequencing, metagenomics and metatranscriptomics can generate profiles based on a population or a specific species related to health vs disease state.
Additionally, it can present transcriptional profiles based on gene expression and this could provide biomarkers. 69 If an expression profile for a specific pathogen can be associated with an infection then a subset of gene targets can be identified. Although useful, there still may be issues with clinical practicality due to cost associations, limited reference databases and data analysis. The transcriptional profile could be beneficial for diagnostics. As time is essential when treating a patient and the identification of a positive culture can take days, most clinicians rely on broad-spectrum antibiotics as a first line of defense.
For targeted antimicrobial therapy to be effective, a system for the rapid identification of an etiological agent is necessary. By generating a model for expression in certain infectious diseases, sequencing and polymerase chain reaction-based methods can facilitate an increase in personalized treatment.
Alternative strategies to classical approaches should be thor- 
| CONCLUSIONS
The oral community is a complex environment that has evolved into a highly regulated state of harmony between hundreds of microbial species. A disturbance in that natural balance alters the surrounding environment, favoring the colonization of pathogenic species. This change in bacterial composition is correlated with the onset of disease. We now know dental caries and periodontal disease are two diseases related to these modulations in the microbiome homeostasis with S. mutans and P. gingivalis playing critical roles. Conventional methods for controlling or reducing plaque biofilm result in the total eradication of the microbiome. Unfortunately, this only fuels the imbalance by removing the beneficial colonizers and allowing for pathogenic microorganisms to re-colonize. Therefore, clinical treatment should aim to re-establish the equilibrium by targeting key pathogens (Figure 2 ).
Although we highlighted studies for specifically targeting S. mutans and P. gingivalis, it is important to note that the aim of F I G U R E 2 Targeted antimicrobial treatment to restore the microbial homeostasis. Various factors including manipulation by keystonepathogens and changes in diet and other host factors can alter the oral environment leading to changes in the microbial population. The altered environment selects for the growth of certain species, reducing the healthy, microbial diversity. Potential strategies such as the identification of pathogen-selective essential gene targets, the dispersal of the pathogenic biofilm or the selective delivery of antimicrobial agents could be used to only eliminate the dysbiotic or pathogenic species. This would allow for the re-establishment of the healthy microbial population and restore homeostasis targeted therapeutics would be to re-establish homeostasis. These strategies could be applied to other acidogenic or periodontitisassociated bacteria. The use of CSP for STAMP technology may not be effective for all strains of S. sobrinus, another contributor to dental caries, but a bactericidal agent could be linked with other speciesspecific delivery systems. Targeted therapy has become fundamental in other areas such as cancer therapy. Similarly, treatment for disease and other infections should adopt an individualized treatment geared towards the specific infection and patient. The development of targeted strategies antibiotics may prove more effective as previously discounted drugs with limited activity can be revisited, screening and testing may be more feasible in a smaller subset and different approaches can be used based on the pathogen of interest. Therefore, it is imperative that we look at where we are and ask how we can further progress species-selective antibiotic drug development.
